NovaBridge Biosciences (NBP) Exchange Rate Effect (2019 - 2025)

NovaBridge Biosciences (NBP) posted quarterly Exchange Rate Effect of $187000.0 for Q4 2025, up 3216.67% year-on-year from $5638.2 in Q4 2024, and up 156.16% on a QoQ basis from $73000.0 in Q3 2025.

NovaBridge Biosciences (NBP) Exchange Rate Effect (2019 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has reported Exchange Rate Effect for 4 consecutive years, with $187000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Exchange Rate Effect rose 3216.67% year-over-year to $187000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $853000.0 (up 104.21% YoY) and the FY2025 annual result came in at $276000.0, down 51.83% from the prior year.
  • Exchange Rate Effect climbed to $187000.0 in Q4 2025 per NBP's latest filing, from $73000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for NBP reached as high as $599000.0 in Q3 2024 and fell as low as -$6000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 619,347.27
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 19.32 Mn
4 NuCana 279.75 Bn 279.75 Bn - 14,631.83
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -40.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -900,000.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 NovaBridge Biosciences 389.86 Mn 389.86 Mn - 187,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 187,000.00
Dec 31, 2025 187,000.00
Sep 30, 2025 73,000.00
Sep 30, 2025 73,000.00
Dec 31, 2024 -6,000.00
Dec 31, 2024 -6,000.00
Sep 30, 2024 599,000.00
Sep 30, 2024 599,000.00
Dec 31, 2020 -17.61 Mn
Dec 31, 2020 -17.61 Mn
Sep 30, 2020 -3.23 Mn
Sep 30, 2020 -3.23 Mn
Dec 31, 2019 -8.86 Mn
Dec 31, 2019 -8.86 Mn